PERRIGO COMPANY PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - ILa | -.--% |
|
-2.55% | -3.73% |
| Jul. 11 | Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating | MT |
| Jul. 10 | Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERRIGO COMPANY PLC | Other Pharmaceuticals | -.--% | -2.55% | - | - | - | 3.7B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- PRGO Stock
- PRGO Stock
- Charts Perrigo Company plc
- Comparison Chart
